Ir Meeting Scheduled For May 20-21, 2026
19/05/2026 05:32
SK Biopharmaceuticals Co Ltd 326030.KS: SK BIOPHARMACEUTICALS CO LTD - IR MEETING SCHEDULED FOR MAY 20-21, 2026 Source text: [ID:] Further company coverage: 326030.KS
Recent news on SK Biopharmaceuticals
See all newsBrief: Sk Biopharmaceuticals Co Signs Licensing-In Contract With 1St Biotherapeutics
US FDA pauses new enrollment in Biohaven's epilepsy drug trials (updated)
US FDA pauses new enrollment in Biohaven's epilepsy drug trials
Biohaven jumps on SK Biopharma epilepsy licensing deal worth up to $795 million
U.S. STOCKS ON THE MOVE-Meta, Kohl's, J.M. Smucker